Literature DB >> 19407124

Role of NO synthase in the development of Trypanosoma cruzi-induced cardiomyopathy in mice.

Jorge L Durand1, Shankar Mukherjee, Fernando Commodari, Andrea P De Souza, Dazhi Zhao, Fabiana S Machado, Herbert B Tanowitz, Linda A Jelicks.   

Abstract

Trypanosoma cruzi infection results in an increase in myocardial NO and intense inflammation. NO modulates the T. cruzi-induced myocardial inflammatory reaction. NO synthase (NOS)1-, NOS2-, and NOS3-null mice were infected with T. cruzi (Brazil strain). Infected NOS1-null mice had increased parasitemia, mortality, and left ventricular inner diameter (LVID). Chronically infected NOS1- and NOS2-null and wild-type mice (WT) exhibited increased right ventricular internal diameter (RVID), although the fold increase in the NOS2-null mice was smaller. Infected NOS3-null mice exhibited a significant reduction both in LVID and RVID. Reverse transcriptase-polymerase chain reaction showed expression of NOS2 and NOS3 in hearts of infected NOS1-null and WT mice, whereas infected NOS2-null hearts showed little change in expression of other NOS isoforms. Infected NOS3-null hearts showed an increase only in NOS1 expression. These results may indicate different roles for NOS isoforms in T. cruzi-induced cardiomyopathy.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19407124      PMCID: PMC2699411     

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  39 in total

1.  Endothelial nitric oxide gene knockout mice: cardiac phenotypes and the effect of angiotensin-converting enzyme inhibitor on myocardial ischemia/reperfusion injury.

Authors:  X P Yang; Y H Liu; E G Shesely; M Bulagannawar; F Liu; O A Carretero
Journal:  Hypertension       Date:  1999-07       Impact factor: 10.190

Review 2.  Chagas cardiomyopathy and ischemic stroke.

Authors:  Francisco Javier Carod-Artal
Journal:  Expert Rev Cardiovasc Ther       Date:  2006-01

3.  nNOS gene deletion exacerbates pathological left ventricular remodeling and functional deterioration after myocardial infarction.

Authors:  Dana Dawson; Craig A Lygate; Mei-Hua Zhang; Karen Hulbert; Stefan Neubauer; Barbara Casadei
Journal:  Circulation       Date:  2005-12-13       Impact factor: 29.690

Review 4.  The emerging role of neuronal nitric oxide synthase in the regulation of myocardial function.

Authors:  Barbara Casadei
Journal:  Exp Physiol       Date:  2006-09-21       Impact factor: 2.969

5.  Dyskinesis in Chagasic myocardium: centerline analysis of wall motion using cardiac-gated magnetic resonance images of mice.

Authors:  Jorge L Durand; Baiyu Tang; David E Gutstein; Stefka Petkova; Mauro M Teixeira; Herbert B Tanowitz; Linda A Jelicks
Journal:  Magn Reson Imaging       Date:  2006-05-26       Impact factor: 2.546

6.  MR imaging of caveolin gene-specific alterations in right ventricular wall thickness.

Authors:  Andrea Pereira De Souza; Alex W Cohen; David S Park; Scott E Woodman; Baiyu Tang; David E Gutstein; Stephen M Factor; Herbert B Tanowitz; Michael P Lisanti; Linda A Jelicks
Journal:  Magn Reson Imaging       Date:  2005-01       Impact factor: 2.546

7.  Expression of cardiac cytokines and inducible form of nitric oxide synthase (NOS2) in Trypanosoma cruzi-infected mice.

Authors:  H Huang; J Chan; M Wittner; L A Jelicks; S A Morris; S M Factor; L M Weiss; V L Braunstein; C J Bacchi; N Yarlett; M Chandra; J Shirani; H B Tanowitz
Journal:  J Mol Cell Cardiol       Date:  1999-01       Impact factor: 5.000

8.  Application of cardiac gated magnetic resonance imaging in murine Chagas' disease.

Authors:  L A Jelicks; J Shirani; M Wittner; M Chandra; L M Weiss; S M Factor; I Bekirov; V L Braunstein; J Chan; H Huang; H B Tanowitz
Journal:  Am J Trop Med Hyg       Date:  1999-08       Impact factor: 2.345

Review 9.  The role of nitric oxide in the pathogenesis of Chagas disease.

Authors:  Joao S Silva; Fabiana S Machado; Gislaine A Martins
Journal:  Front Biosci       Date:  2003-05-01

10.  Thromboxane A2 is a key regulator of pathogenesis during Trypanosoma cruzi infection.

Authors:  Anthony W Ashton; Shankar Mukherjee; F N U Nagajyothi; Huan Huang; Vicki L Braunstein; Mahalia S Desruisseaux; Stephen M Factor; Lillie Lopez; Joan W Berman; Murray Wittner; Philipp E Scherer; Valerie Capra; Thomas M Coffman; Charles N Serhan; Katherine Gotlinger; Kenneth K Wu; Louis M Weiss; Herbert B Tanowitz
Journal:  J Exp Med       Date:  2007-04-09       Impact factor: 14.307

View more
  10 in total

1.  Imaging the Gastrointestinal Tract of Small Animals.

Authors:  Linda A Jelicks
Journal:  J Neuroparasitology       Date:  2010-01-01

2.  Curcumin treatment provides protection against Trypanosoma cruzi infection.

Authors:  Fnu Nagajyothi; Dazhi Zhao; Louis M Weiss; Herbert B Tanowitz
Journal:  Parasitol Res       Date:  2012-01-04       Impact factor: 2.289

3.  Microarray analysis of the mammalian thromboxane receptor-Trypanosoma cruzi interaction.

Authors:  Herbert B Tanowitz; Aparna Mukhopadhyay; Anthony W Ashton; Michael P Lisanti; Fabiana S Machado; Louis M Weiss; Shankar Mukherjee
Journal:  Cell Cycle       Date:  2011-04-01       Impact factor: 4.534

Review 4.  Trypanosoma cruzi antioxidant enzymes as virulence factors in Chagas disease.

Authors:  Lucía Piacenza; Gonzalo Peluffo; María Noel Alvarez; Alejandra Martínez; Rafael Radi
Journal:  Antioxid Redox Signal       Date:  2012-05-21       Impact factor: 8.401

Review 5.  Imaging of small-animal models of infectious diseases.

Authors:  Linda A Jelicks; Michael P Lisanti; Fabiana S Machado; Louis M Weiss; Herbert B Tanowitz; Mahalia S Desruisseaux
Journal:  Am J Pathol       Date:  2012-11-28       Impact factor: 4.307

Review 6.  The potential of nitric oxide releasing therapies as antimicrobial agents.

Authors:  David O Schairer; Jason S Chouake; Joshua D Nosanchuk; Adam J Friedman
Journal:  Virulence       Date:  2012-05-01       Impact factor: 5.882

7.  NADPH phagocyte oxidase knockout mice control Trypanosoma cruzi proliferation, but develop circulatory collapse and succumb to infection.

Authors:  Helton C Santiago; Claudia Z Gonzalez Lombana; Juan P Macedo; Lara Utsch; Wagner L Tafuri; Maria José Campagnole-Santos; Rosana O Alves; José C F Alves-Filho; Alvaro J Romanha; Fernando Queiroz Cunha; Mauro M Teixeira; Rafael Radi; Leda Q Vieira
Journal:  PLoS Negl Trop Dis       Date:  2012-02-14

8.  Disease Tolerance and Pathogen Resistance Genes May Underlie Trypanosoma cruzi Persistence and Differential Progression to Chagas Disease Cardiomyopathy.

Authors:  Christophe Chevillard; João Paulo Silva Nunes; Amanda Farage Frade; Rafael Ribeiro Almeida; Ramendra Pati Pandey; Marilda Savóia Nascimento; Jorge Kalil; Edecio Cunha-Neto
Journal:  Front Immunol       Date:  2018-12-03       Impact factor: 7.561

9.  Differences in cNOS/iNOS Activity during Resistance to Trypanosoma cruzi Infection in 5-Lipoxygenase Knockout Mice.

Authors:  Carolina Panis; Vanessa Jacob Victorino; Vera Lúcia Hideko Tatakihara; Rubens Cecchini; Luiz Vicente Rizzo; Lucy Megumi Yamauchi; Sueli Fumie Yamada-Ogatta; Marli Cardoso Martins-Pinge; Phileno Pinge-Filho
Journal:  Mediators Inflamm       Date:  2019-10-24       Impact factor: 4.711

10.  Response to Trypanosoma cruzi by Human Blood Cells Enriched with Dentritic Cells Is Controlled by Cyclooxygenase-2 Pathway.

Authors:  Sandra C H Lonien; Aparecida D Malvezi; Helena T Suzukawa; Lucy M Yamauchi; Sueli F Yamada-Ogatta; Luiz V Rizzo; Juliano Bordignon; Phileno Pinge-Filho
Journal:  Front Microbiol       Date:  2017-10-25       Impact factor: 5.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.